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1. Introduction 
Coeliac disease is a complex inflammatory disorder of the small intestine with autoimmune 
features in genetically predisposed individuals and triggered by chronic exposure to gluten 
of wheat, barley and/or rye (Trynka et al., 2010). The aim of the recent chapter is to 
introduce and characterize a family of proteins, called heat shock proteins (HSPs), which are 
known to be key molecules during stress responses (Polla & Cossarizza, 1996). We will 
discuss the potential involvement of HSPs in the pathomechanism of coeliac disease based 
on recent scientific results. We will also refer to some future directions and potential 
therapeutic intervention.  
1.1 What is coeliac disease?  
Coeliac disease also known as gluten-sensitive enteropathy or nontropical sprue is a 
digestive disease occurring in genetically susceptible individuals, triggered by dietary 
gluten and related prolamins, which damage small intestine and interfere with absorption of 
nutrients (Setty et al., 2008). Gluten and prolamins are present in wheat, rye and barley, but 
also in some products such as stamp and envelope adhesive, medicines, and vitamins 
(Rodrigo, 2009). The genetic predisposition has been associated with the major 
histocompatibility complex region on chromosome 6p21. More than 90% of coeliac disease 
patients express the antigen-presenting molecules human leukocyte antigen-DQ2 and the 
remaining coeliac patients express DQ8 (Silano et al., 2010; Schuppan et al., 2005). 
Approximately 1% of the population is affected by coeliac disease (it remains mostly 
undiagnosed) (Green, 2005). It is not clear, why the prevalence of coeliac disease increased 
over the last decades, but similarly to other immune mediated diseases ― such as allergy or 
asthma ― this tendency suggests the importance of environmental stress factors besides the 
genetic predisposition (Rubio-Tapia & Murray, 2010). In addition, novel and trustful 
diagnostic marker (tissue transglutaminase) could help to uncover previously undiagnosed 
cases. Coeliac disease was traditionally considered to be a childhood disease, however, most 
patients are diagnosed in adulthood (Virta et al., 2009). Coeliac disease often becomes active 
for the first time after surgery, pregnancy, childbirth, viral infection, emotional or other 
stress situations (Baldassarre et al., 2008). Concepts/hypothesis such as the hygiene 
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hypothesis, perhaps changes in wheat or other cereals may lead to the increased prevalence 
of coeliac disease. The disease leads to intestinal inflammation, villous atrophy, and crypt 
hyperplasia of the small intestine (Kaukinen et al, 2010). Furthermore coeliac disease may be 
associated with various extra-intestinal complications, including isolated iron deficiency 
anemia (Doganci & Bozkurt, 2004), bone and skin disease (Maniar et al., 2010; Reunala, 
2001), infertility, endocrine and neurologic disorders (Gupta & Kohli, 2010). Presumed 
disease is mainly detected by serologic screening for the presence of tissue transglutaminase 
specific immunglobulin A antibodies, and this should be followed by taking biopsy samples 
from the small intestine mucosa to establish a definite diagnosis (Rostom et al., 2005). In the 
pathomechanism of coeliac disease both the adaptive and innate immunity may be 
involved. The importance of the adaptive immune response to gluten has been well 
established, but recent observations also suggest the central role for the gluten-induced 
innate stress response in the pathogenesis of coeliac disease (Jabri & Sollid, 2006). It is 
characterized by the presence of lymphocytic infiltration in the epithelial membrane and the 
lamina propria, and expression of multiple cytokines and signaling proteins (Briani et al., 
2008). Recently gluten-free diet is the most effective mode to treat coeliac disease (Fric et al., 
2011). 
1.2 How is stress involved in the development and pathomechanism of coeliac 
disease? 
As mentioned above there is a broad spectrum of environmental, genetic and immunologic 
factors, which may be involved in the development of coeliac disease. Here we focus on the 
common effects of different stress factors in the pathogenesis of coeliac disease. Stress is an 
acute menace to the homeostasis of an organism that may have both a short- and long-term 
influence on the function of the organs. Stress evokes adaptive responses that serve to 
defend the stability of the internal environment and to ensure the survival of the organism 
(Bhatia & Tandon, 2005). There are several types of stress circumstances: intrinsic, such as 
genetic and endoplasmic reticulum stress; extrinsic/environmental including heat-, toxin-, 
radiation-, infection- and injury-induced stress, mechanical and regenerative stress; 
metabolic stress such as hypoxia-induced, osmotic and oxidative stress. Under normal 
circumstances the epithelial cells are connected to each other with tight junctions and 
adherent junctions in the small intestine and in the large bowel as well. These structures of 
the epithelial cells serve as a barrier and inhibit the transcellular and paracellular 
permeation of molecules (Turner, 2009). Mechanical, chemical or oxidative stress can impair 
mucosal integrity (Lewis, 2009), modulate gut motility, epithelial barrier function (John et 
al., 2011) and inflammatory states (Lyte et al., 2011) and in genetically susceptible persons 
may lead to the development of coeliac disease (Szaflarska-Poplawska et al., 2011), because 
incompletely digested peptides of wheat gluten (gliadin and glutenins) and related proteins, 
as dietary antigens, can be transported across the epithelium and enter into the lamina 
propria of the small intestine (Alaedini & Green, 2005). The major processes of the 
pathogenesis of coeliac disease are shown on Figure 1.  
Tissue transglutaminase 2 enzymes, which are the components of endomysium, become 
activated in the intestinal mucosa (lamina propria) (Schuppan et al.,  2009). 
Transglutaminase 2 is a calcium-dependent enzyme which catalyzes protein cross-linking, 
polyamination or deamidation at selective glutamine residues (Caccamo et al., 2010) and  
 




Fig. 1. Major processes of the pathogenesis of coeliac disease. (For explanation see text) 
Abbreviations: TG: transglutaminase; APC: antigen presenting cell; T: T lymphocyte; B: B 
lymphocyte; Fb: fibroblast; IEL: intraepithelial lymphocyte 
may be involved in different pathological conditions, such as neurodegenerative disorders 
(Malorni et al., 2008), tumour progression (Chhabra et al., 2009), autoimmune and 
inflammatory diseases (Elli et al., 2009). Due to its activity neutral glutamine residues of the 
gluten protein will be deamidated and can be converted into negatively charged glutamic 
acids, creating epitopes with increased immunostimulatory potential (Briani et al., 2008). 
Some of the deamidated gliadins may cross-link to transglutaminase and form covalently 
linked complexes (Alaedini & Green, 2008; Fleckenstein et al, 2004). Antigen presenting 
immune cells such as macrophages, dendritic cells and B lymphocytes present the 
deamidated peptides or complexes through their disease associated human leukocyte 
antigen-DQ2 and human leukocyte antigen-DQ8 molecules to CD4+ T helper cells in the 
lamina propria (Qiao et al, 2009). Activated T cells promote B cell maturation, isotype 
switch, and differentiation into plasma cells producing anti-gluten and anti-
transglutaminase 2 antibodies (Sollid, 2000). Furthermore activated T cells express 
proinflammatory cytokines, such as tumor necrosis factor alpha and interferon gamma, 
which trigger the release of matrix metalloproteinases by fibroblasts causing epithelial cell 
damage, degradation of the mucosal matrix and tissue remodeling (Schuppan et al., 2009). 
Interleukin-15 secreted by epithelial cells in response to gluten exposure activates 
intraepithelial CD8+ T lymphocytes called cytotoxic T cells, which can destroy epithelial 
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cells, that express stress-induced non-classical major histocompatibility complex class I 
ligands and human leukocyte antigen E molecules (Briani et al., 2008; Jabri et al., 2005). 
Gliadin peptides can also directly elicit innate immune responses in macrophages and 
dendritic cells via pattern recognition receptors such as Toll-like receptor 2 and 4 (Szebeni et 
al., 2007). Mammalian Toll-like receptors comprise a family of type I transmembrane 
receptors, which originally recognize conserved pathogen-associated molecular patterns of 
different microorganisms (Medzhitov, 2001). Activation of Toll-like receptors leads to the 
upregulation of major histocompatibility complexes, costimulatory molecules and 
expression of proinflammatory cytokines and chemokines (Takeda et al, 2003). These stress-
induced reactions lead to damage of the epithelial cells in the small intestine, which results 
in increased permeability, loss of barrier function and aggravation of the disease (Sollid & 
Jabri, 2005).  
2. Stress inducible proteins: their role and classification 
There are some major key molecules or processes, namely basement membrane degradation, 
oxidative stress, apoptosis, effect of matrix metalloproteinases and dysregulation of 
proliferation and differentiation, which are thought to play role in the pathophysiology of 
coeliac disease (Diosdado et al., 2004), however the exact pathomechanism is not fully 
understood. Here we focus on stress circumstances, as critical factors in the initiation and 
pathogenesis of coeliac disease (Lewis & McKay, 2009). Among several other diseases there 
are increasing evidences between stress and various gastrointestinal disorders, such as 
inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, gastrointestinal 
reflux disease (Levenstein et al., 2000; Gué et al., 1997). Organisms must be able to sense and 
respond rapidly to changes in their environment in order to maintain homeostasis and 
survive. Therefore as consequence of stress several processes and molecules become 
activated. Based on the review by Richter K. et al. these proteins can be grouped into classes, 
namely molecular chaperones (called as HSPs), components of the proteolytic system, 
RNA/DNA modifying enzymes, metabolic enzymes, regulatory proteins, cell organisatory 
proteins and transport, detoxifying and membrane-modulating proteins (Richter et al., 2010) 
(Table 1).   
The first discovered stress inducible proteins, called HSPs are recently referred to as 
“molecular chaperones” (discussed in details later). They are involved in adequate folding 
of proteins, which means, that these ubiquitous, conserved proteins help other proteins and 
macromolecules to fold or re-fold and reach their final, native conformation (Papp et al., 
2003). Cells are equipped with an efficient surveillance system to selectively eliminate 
abnormally folded, damaged proteins (Mishra et al., 2009). First with the help of molecular 
chaperones the cell tries to refold the unfolded proteins (Bukau et al, 2006), but if the 
refolding is no more possible, the misfolded or irreversibly aggregated proteins will be 
degraded by the ubiquitin proteasome system (Shang & Taylor, 2011). In the second class of 
proteins belong the components of the ubiquitin-proteasome pathway, which is the primary 
cytosolic proteolytic machinery for the selective degradation of various forms of damaged 
proteins, so it is an important protein quality control mechanism (Dantuma & Lindsten, 
2010). Degradation of the target protein by ubiquitin proteasome system is a multistep 
process consisting of activating, conjugating, and ligating enzymes to ensure covalent 
attachment of multiple molecules of ubiquitin to the target proteins, which finally leads to  
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# Functional protein 
class name 
Function Examples Reference 
1. Molecular 
chaperones (HSPs) 
Role in protein folding, 
decrease the amount of 
nonnative proteins and 
unwanted intermolecular 
interactions  
HSP (heat shock 




2. Proteolytic system 
components 
Help to eliminate misfolded 









Necessary to repair DNA 
damage and failures, that occur 
during stress 
DNA helicase, RNAse p 
subunit, topoisomerase 
,  Jantschitsch & 
Trautinger, 2003; 
Biamonti & Caceres, 
2009 
4. Metabolic enzymes Cell energy supply stabilization 





 Malmendal et al., 
2006 
5. Regulatory proteins Transcription factors or kinases 
to regulate stress responses 
CREB, Fas, HSF  Akerfelt et al., 2007 
6. Cell organisatory 
proteins 
Sustain cellular structures such 
as cytoskeleton 
claudin, actin, Las 17 
(actin patch protein)  





Stabilization of membrane 




 Vigh et al., 2007 
Table 1. Functional classification of proteins induced by heat stress response. For 
explanations see text. Abbreviations: HSP: heat shock protein; NADH: nicotinamide adenine 
dinucleotide; CREB: cAMP response element-binding; Fas: FS7-associated cell surface 
antigen; HSF: heat shock factor; ABC: ATP binding cassette. (Based on review of Richter K. 
et al., 2010) 
degradation of the targeted protein by 26S proteasome complex (Glickman & Ciechanover, 
2002). The third functional class of proteins (involved in the response to stress) is the group 
of DNA/RNA modifying enzymes. They are essential to repair DNA damage that occurs 
during stress (Jantschitsch & Trautinger, 2003; Biamonti & Caceres, 2009). The fourth class is 
that of metabolic enzymes, which are involved in cell energy supply stabilization and 
reorganization during and after stress. Malmendal et al. characterized the metabolomic 
profile of Drosophila melanogaster after heat stress exposure, and found relatively reduced 
level of some metabolites following shock compared to controls, which were involved in 
energy metabolism (Malmendal et al., 2006). They described that following heat stress 
energy storage were decreased in the form of reduced glycogen and fatty acid-like or lipid-
like molecules and glucose levels (Malmendal et al., 2006). During stress response regulating 
proteins such as transcription factors and kinases play also crucial role. They are involved in 
further initiation of signaling pathways in response to stress or have role in ribosome 
biogenesis and assembly (Al Refaii & Alix, 2009). One family of the most important 
transcription factors involved in stress response is that of heat shock factors (Akerfelt et al., 
2007). Heat shock factors play significant role in suppressing protein misfolding in cells by 
the induction of classical as well as of nonclassical heat shock genes, both of which might be 
required to maintain protein homeostasis (Fujimoto & Nakai, 2010). Proteins involved in 
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maintenance of cell structure, such as the cytoskeleton, are also significantly induced by 
stress (Richter et al., 2010). RNA expression and protein levels of the cytoskeletal 
intermediate filaments, which are essential to the structural integrity of epithelial cells 
(Sivaramakrishnan et al., 2008), become induced several fold in response to a variety of 
stress circumstances (Toivola et al., 2010). Initially intermedier filaments were described as 
molecules, which protect cells and tissues from mechanical stress (Kim & Coulombe, 2007; 
Pekny & Lane, 2007). Due to their special properties namely that their filaments can stretch 3 
times their initial length before breaking, intermedier filaments are unique among 
cytoskeletal proteins (Wagner et al, 2007). The seventh functional group comprises 
upregulated transport, detoxifying and membrane-modulating proteins (Richter K. et al., 
2010). The major role of these proteins is the stabilization of the membrane and preservation 
of its original function (Welker et al., 2010). Stress induces alterations in the lipid phase of 
membranes and lipids are known to influence the distribution of proteins within 
membranes (Vigh et al., 2007). It was also described, that stress stimuli alter the gene 
expression of multidrug resistance gene 1, which codes an ATP-dependent membrane-
bound transporter called P-glycoprotein (Sharom, 2008). Transporters, such as members of 
ATP-binding cassette-superfamily are multidrug efflux pumps, play important role in cell 
protection against harmful chemicals, toxic xenobiotics and endogenous metabolites and 
they are also involved in the cellular response against stress (Sukhai & Piquette-Miller, 
2000). It has been reported a direct correlation between multidrug resistance gene 1 and heat 
shock response, and basal activity of the multidrug resistance gene 1 promoter requires heat 
shock factor-mediated transactivation (Kim et al., 1997). Our present study provides an 
overview about functional groups of proteins potentially involved in stress response. 
Hereinafter we will focus especially on heat shock proteins commonly referred to as 
“molecular chaperones”(Ellis et al., 1989). 
3. What are heat shock proteins? 
Temperatures above the optimum may sensed as heat stress by living organisms, which 
disturbs cellular homeostasis and can lead to severe retardation in growth and 
development, and even to death (Baniwal et al., 2004). It has been shown, that cells response 
to heat stress by increased expression of heat stress proteins (Stetler et al., 2010). HSPs ― also 
referred to as extrinsic chaperones or “molecular chaperones” ― are a suite of highly 
conserved proteins with various molecular weights, which are produced in all organisms, 
when those are exposed to cellular stress (Welch, 1993). The discovery of HSPs started in the 
early 1960s (Ritossa, 1962). Ritossa et al. observed different puffing pattern of the 
chromosomes in Drosophila melanogaster after shifting the incubator temperature (Ritossa, 
1996). Later these puffs were found to code proteins, which were identified as HSPs (Moran 
et al., 1978).  When eukaryotic cells were exposed to temperatures 5-15 °C above their 
optimum for growth, they responded also by induction of HSPs (DiDomenico et al., 1982). 
These molecules were found also in prokaryotes and other eukaryotes (Lemaux et al., 1978; 
Carper et al., 1987; Kelley & Schlesinger, 1978; Timperio et al., 2008). HSPs are evolutionally 
highly conserved proteins indicating that heat shock response may be universal mechanism 
(Richter et al., 2010). Early on, researchers suggested that HSPs function as molecular 
chaperones mediating the folding and assembly of polypeptides and their translocation 
across the intracellular membranes (Burel et al., 1992). HSPs are also involved in protein 
degradation as essential components of the ubiquitin-dependent degradative pathway 
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(Morandi et al., 1989). The HSP chaperone machinery may stabilize the target protein to 
degradation by the ubiquitin-proteasome pathway of proteolysis (Pratt et al., 2004). These 
functions of HSPs are important during cell repair process after damage. Generally there are 
two major groups of HSPs, constitutive, which are continually present in the cell, and 
inducible HSPs (Petrof et al., 2004). HSPs are rapidly induced by a variety of cellular 
stressors, such as heat, UV light, or cytotoxic agents (Rajaiah & Moudgil, 2009; Aufricht, 
2004), ischaemia-reperfusion injury, oxidative stress and nutritional stress (Akerfelt et al, 
2010). Recently our knowledge about their roles have been expanded, including their 
involvement in the modulation of immune responses (Hauet-Broere et al., 2006; Johnson & 
Fleshner, 2006), autoimmunity (Rajaiah & Moudgil, 2009), cell signaling (Csermely et al., 
2007), cell proliferation (Pechan, 1991), and apoptosis (Padmini & Lavanya, 2011). The 
expression of HSPs has been reported in several tissues and cell types, including heart 
(Ghayour-Mobarhan, 2009), brain (Stetler, 2010), muscle (Geiger & Gupte, 2011), lung 
(Wong & Wispé, 1997), kidney (Kelly, 2005), liver (Tashiro, 2009) and intestinum (Asano et 
al., 2009). It is also known, that HSPs are overexpressed in a wide range of human cancers 
and are implicated in tumour cell proliferation, differentiation, invasion, metastasis, death, 
and recognition by the immune system (Ciocca & Calderwood, 2005). HSPs can be classified 
into five major families, namely HSP60s, HSP70s, HSP90s, HSP100s and small HSPs (Richter 
et al., 2010; Roberts et al., 2010) based on their molecular weight. There are also some not 
ubiquitous HSPs, for example redox-regulated chaperon HSP33, which can not be ranked 
into these classical groups (Graf & Jakob, 2002). Major families of HSPs can be seen on Table 
2. 
 




Example members Cellular localization 
1. HSP100 80-110 kDa HSP100, HSP104 
cytoplasm, nucleus, mitochondia, 
plasma membrane 
2. HSP90 82-96 kDa 
HSP90α (inducible), 
HSP90β 
cytoplasm, nucleus, mitochondria, 
endoplasmic reticulum 
3. HSP70 67-76 kDa 
HSP70, HSP72, 
HSP73, HSP80 
cytoplasm, nucleus, mitochondria, 
endoplasmic reticulum, lysosomes and 
extracellular compartments 
4. HSP60 58-65 kDa HSP60, HSP65 mitochondria 









various HSP33 various 
Table 2. Major families of HSPs. For explanations see text. (Based on review of Roberts et al., 
2010 and Otaka et al., 2006) 
3.1 HSP100 family  
The HSP100 proteins belong to the superfamily of AAA (ATPase associated with various 
cellular activities) + domain-containing ATPases (Mayer, 2010). They are localized to 
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different subcellular compartments, such as cytoplasm, nucleus, mitochondria and plasma 
membrane (Singh & Grover, 2010). Interestingly HSP100 proteins and also their 
homologues are absent in Archaea (Large et al., 2009), but they are found in Bacteria and 
Eukaryotes (Barends et al, 2010). Main function of HSP100 proteins is that they protect 
organisms under extreme stress conditions. It was demonstrated on heat-shocked yeast 
that their survival is significantly reduced in the absence of HSP100 protein (Schirmer et 
al., 1996). HSP100 molecules function as chaperones in an ATP-dependent fashion leading 
either to the renaturation or proteolytic degradation of individual proteins (Parsell & 
Lindquist, 1993; Liang & MacRae, 1997). They are important components of the protein 
quality control system controlling the intracellular levels of global regulatory proteins 
(Maurizi & Xia, 2004). It was demonstrated, that HSP104, a member of HSP100 family 
collaborates with the HSP70 chaperone systems to reactivate stress-denatured proteins 
from aggregates, which mechanism is crucial for the survival of cells during severe stress 
(Miot et al., 2011).  
3.2 HSP90 family 
Members of the 90 kDa heat shock proteins (HSP90) family are expressed in various 
organisms ranging from prokaryotes to eukaryotes (Pearl & Prodromou, 2006). They are one 
of the most highly abundant constitutively expressed proteins, comprising 1–2% of cellular 
proteins. HSP90 proteins are involved in various cellular processes, such as controlling of 
cell proliferation, differentiation and apoptosis and their expression increases markedly 
during stress (Sreedhar et al., 2004; Liang & MacRae, 1997). Eukaryotes require a functional 
cytoplasmic HSP90 for their viability: these proteins have role in the folding of a set of cell 
regulatory proteins and in the re-folding of stress-denatured polypeptides (Obermann et al., 
1998; Borkovich et al., 1989). HSP90 proteins are ATP-dependent chaperones and the 
chaperone machine is driven by the hydrolysis of ATP and ADP/ATP nucleotide exchange. 
This ATP hydrolysis is coupled to conformation changes of HSP90s, which facilitate target 
protein folding and maturation (Hao et al, 2010). Recently several HSP90 members have 
been identified in mammalian cells, including the two major cytoplasmic homologues, the 
inducible HSP90-alpha and the constitutive HSP90-beta, the glucose-regulated protein 94 in 
the endoplasmic reticulum, and tumor necrosis factor receptor-associated protein 1 in the 
mitochondrial matrix (Stetler et al., 2010). Interestingly the bacterial homologue of HSP90 
called HtpG is dispensable under non-heat stress conditions (Thomas & Baneyx, 1998). 
HSP90s contains nine alpha-helices and eight anti-parallel beta pleated sheets, which 
combine to form several alpha/beta sandwiches. HSP90 chaperones exist as obligate 
homodimers, and each monomer consist of an N-terminal regulatory domain, a non-
conserved and dispensable charged region, a middle domain, and a C-terminal dimerization 
domain (Dollins et al., 2007).  
A recent study demonstrates that inhibition of HSP90s abrogates the protective effect of 
bone marrow stromal cells, inhibits angiogenesis and osteoclastogenesis and a HSP90 
inhibitor called tanespimycin is able to reduce tumour cell survival in vitro (Richardson et 
al., 2011). Because HSP90 chaperones play essential housekeeping functions and may be 
involved in a broad range of processes from signal transduction to immune responses, 
inhibitors may be promising for novel therapies (Sharp & Workman, 2006).  
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3.3 HSP70 family 
70 kDa heat shock proteins (HSP70s) are the major components of the network of molecular 
chaperones, which are ubiquitously expressed, highly conserved and may be involved in a 
wide range of folding processes such as modulating polypeptide folding, degradation and 
translocation across membranes, as well as protein-protein interactions (Ryan & Pfanner, 
2001). The HSP70 family is a most widely studied group of chaperones and comprises at 
least 13 related proteins expressed constitutively or induced by stress response and exert 
important cellular housekeeping functions (Daugaard et al., 2007). They can be found in 
cytoplasm, nucleus, mitochondria, endoplasmic reticulum, lysosomes and extracellular 
compartments (Stetler et al., 2010). While certain family members, such as HSP73 also 
known as heat shock cognate 70 is constitutively expressed in the cytosol, transcription of 
HSP72 is highly responsive to stress (Evans et al., 2010). HSP70 chaperones operate by an 
ATP dependent manner, namely their polypeptide binding and release capacity is driven by 
ATP. Various nucleotide exchange factors and co-chaperones (for example the so called 
DnaJ proteins, which associate with HSP70s and may control their nucleotide turnover 
(Laufen et al., 1999)) may promote the HSP70 ATPase cycle (Young, 2010). HSP70s may 
exert important cytoprotective functions in gastric and colonic mucosa (Odashima et al., 
2002; 2006).  
3.4 HSP60 family 
A special group of chaperones and comolecules exist in the organisms, which is involved in 
mitochondrial protein folding. Such proteins are the members of the HSP60 family also 
called as chaperonins. HSP60s are essential for the health and maintenance of mitochondrial 
function, as well as for proper mitochondrial biogenesis (Stetler et al, 2010). Although the 
majority of HSP60 proteins can be found in the mitochondria, 15–20% of them is located 
extramitochondrially (in the cytosol, on the cell surface or in the extracellular space) (Soltys 
& Gupta, 1996; Pfister et al., 2005). In the animal model of transient global ishaemia, HSP60s 
can be induced during stress (Truettner et al., 2009). Kuwabara et al. also have found that 
HSP60s are specifically induced in rat colonic mucosa after 5-hydroxytryptamine-induced 
ischaemia and it may have cytoprotective effects (Kuwabara et al., 1994). HSP60 proteins 
also have immunomodulatory functions, because they are activator of Toll-like receptor 4 
signaling in macrophages and dendritic cells and also regulate the activity of effector T cells 
and regulatory T cells via innate Toll-like receptor 2 signaling. It is proposed that HSP60s 
can serve as biomarkers to monitor the immune status of the individual, providing a 
potential to modulate immunity for therapeutic purposes in diseases such as in rheumatoid 
arthritis and type I diabetes (Quintana & Cohen, 2011). 
3.5 Small HSPs 
The family of small HSPs (sHSPs) is the less conserved family of molecular chaperones. 
Their only common characteristics is the conserved alpha-crystallin or HSP20 core domain 
(Richter et al., 2010) named according to its discovery in alpha-crystallin, a highly abundant 
protein in the vertebrate eye lens (Horwitz, 1992). sHPSs have general importance, they are 
present in Archaea, Bacteria, and Eukarya, but there is a broad variation of primary 
sequences within the superfamily and different organisms (Kriehuber et al, 2010). sHSPs are 
ATP-independent chaperones, which forms large oligomers containing often more than 20 
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monomers (Van Montfort et al., 2001). Recent evidences suggest that sHSPs maintain 
protein homeostasis by binding proteins in non-native conformations, thereby preventing 
substrate aggregation (Haslbeck et al., 2005). They are also associated with a variety of 
severe diseases (e.g., myopathies, dystrophies, cataracts, Alzheimer's or other amyloidal 
diseases, and diverse cancers) and their expression is enhanced under environmental stress 
conditions such as elevated temperature or exposure to heavy metals or arsenate (Sun & 
MacRae, 2005; Haslbeck et al., 2005). Major family members alphaB-crystallin, HSP25 and 
HSP27 might be involved in the prevention of apoptosis and cell protection against heat 
shock and oxidative stress, they can stabilize microfilaments (Arrigo, 2007). Modulation of 
the expression and activities of HSP27 and alphaB-crystallin may have therapeutic potential 
in the future (Arrigo et al., 2007). Also ubiquitin, a small protein weighting 8 kD, belongs to 
the family of HSPs and it is involved in nonlysosomal protein degradation, which is an 
important pathway of proteolysis (Kiang, 2004; Heo &Rutter, 2011; von Mikecz et al., 2008). 
4. Regulation of the HSPs 
As mentioned above, cellular events, which lead to protein unfolding or denaturation (such 
as elevated temperature, oxidative stress and metabolic disturbances) can activate heat 
shock response, which leads to the upregulation of HSPs (Noble et al., 2008). Specific 
transcription factors play a key role in these processes: transcription factor sigma 32 in 
prokaryotic cells (Rodriguez et al., 2008) and heat shock factor 1 in eukaryotic cells (Anckar 
& Sistonen, 2007). However sigma 32 and heat shock factor 1 are not related in their 
sequence and structure, they share common mechanistic properties leading to HSP 
overexpression (Richter et al., 2010). In prokaryotes, for example in Escherichia Coli there 
are a HSP70 and a HSP40 chaperone homologes called DnaK and DnaJ, respectively, which 
normally form a complex with the transcription factor sigma 32. Thereby the bound sigma 
32, which is an alternative subunit of the bacterial RNA polymerase, remains in inactive 
state and will be degraded by specific AAA (ATPase associated with various cellular 
activities) proteases called FtsH metalloproteases. Under normal circumstances this 
mechanism results in reduced intracellular level of transcription factor sigma 32, keeping 
the heat shock genes untranscribed (Rodriguez et al., 2008). During stress the protein 
homeostasis is disturbed, the number of unfolded proteins is increased, which then bind to 
DnaK and DnaJ chaperone molecules. Until these chaperones are in complex with unfolded 
proteins, they are no more able to bind the sigma 32 transcription factor, which becomes 
activated. Activated sigma 32 binds to RNA polymerase and replaces the normal regulatory 
σ70 subunit and stimulates the transcription of heat shock genes. Similarly to sigma 32 in 
prokaryotes, in eukaryotes the transcription factor heat shock factor 1 forms complex with 
HSP70 and HSP40 proteins, which keep it in inactive form inhibiting its function. But 
compared to the prokaryotes the function of the heat shock factor 1 regulatory system is 
much more complex, because multimerization, phosphorilation and numerous 
posttranscriptional modifications might be involved in the mechanism (Prahlad & 
Morimoto, 2009). Under stress circumstances the HSPs, also HSP70 and HSP40 bind to 
unfolded proteins losing their ability to form complex with heat shock factor 1, which then 
leads to the release of heat shock factor 1 monomers. After trimerization heat shock factor 1 
is transported into the nucleus and becomes hyperphosphorylated by kinases at multiple 
sites within its regulatory domain (Holmberg et al., 2001). Heat shock factor 1 binds to heat-
shock elements found in the promoter regions of its target HSP genes, which finally leads to 
the transcription of heat shock genes (Figure 2).  
 



































Fig. 2. Regulation of the heat shock response in eukaryotes. Under normal circumstances 
HSPs are in complex with the transcription factor heat shock factor 1. Under stress HSPs 
bind to unfolded proteins (1.) losing their ability to form complex with heat shock factor 1, 
therefore leading to the release of heat shock factor 1 monomers (2.). After trimerization (3.) 
heat shock factor 1 is transported into the nucleus and becomes hyperphosphorylated (4.). 
Heat shock factor 1 then binds to the HSE in the promoter regions of target HSP genes (5.). 
This process leads to the transcription of HSPs. Abbreviations: HSP: heat shock protein; P: 
phosphorylation; HSF1: heat shock factor 1; HSE: heat-shock elements 
On the other hand the formation of HSP-heat shock factor complex suppresses heat shock 
factor production maintaining a negative feed-back regulatory system. Furthermore heat 
shock factor 1 may be inducibly acetylated at a specific residue, which regulates negatively 
its DNA binding activity (Westerheid et al., 2009). Heat shock factor binding protein 1 has 
been reported to be a negative regulator of the heat shock response, because heat shock 
factor binding protein 1  binds specifically the active trimeric form of heat shock factor1, 
thus inhibiting its activity (Liu et al, 2009). 
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5. Molecular functions of HSPs with special focus on coeliac disease 
In this part we introduce the major molecular functions of HSPs in those processes, which 
may be also involved in the pathogenesis of coeliac disease, such as oxidative stress, 
immune response and inflammation, apoptosis and mucosal damage.  
5.1 Oxidative stress 
Different chemical and environmental stressors often act by induction of oxidative damage in 
the cells (Limón-Pacheco & Gonsebatt, 2009). In this process reactive oxygen species play a key 
role. Reactive oxygen species are generated continuously during the respiration process, and 
their level is markedly elevated by a range of different stress conditions causing oxidative 
deterioration of proteins, lipids and DNA (Avery, 2011). When production of reactive oxygen 
species exceeds the capacity of cellular antioxidant defenses to remove these toxic species, it is 
referred as oxidative stress and together with decreased reductive potential it may induce cell 
damage or death (Rivabene et al., 1999). It has been assumed that oxidative stress plays an 
important role in the development of celiac disease, because gliadin can induce oxidative 
stress responses (Diosdado et al., 2005). Gluten peptides could enhance the mRNA expression 
of the inducible form of nitric oxide synthase in the small intestine, (van Straaten et al., 1999). 
Increased inducible nitric oxide synthase and nitric oxide levels contribute to subsequent 
mucosal damage by promoting the generation of peroxynitrite and free-radicals and can play a 
role in the mechanism leading to villous atrophy in coeliac disease (Murray et al., 2002). Levels 
and activity of antioxidant enzymes epoxide hydrolases and glutathione peroxidases and 
other antioxidants, such as a-tocopherol and lipoproteins (cholesterol and apolipoproteins), 
which major biological role is the protection of the organism from oxidative damage, were 
reduced in biopsies taken from patients with coeliac disease (Stojiljković et al., 2007; Odetti et 
al., 1998). In these processes HSPs may be involved in several ways. Oxygen free radicals, such 
as superoxide can be an inducer of HSPs (Omar & Pappolla, 1993). HSP32, also known as 
heme oxygenase-1 enzyme participates in the cell defense against oxidative stress by 
degrading heme to vasoactive carbon monoxide, free iron, and to potent antioxidant biliverdin 
(Aztatzi-Santillán et al., 2010). HSP60 plays a role in protecting small intestinal mucosal cells 
from H2O2-induced cell injury by enhancing the cytoprotective function of small intestinal 
epithelial cells (Takada et al., 2010). After hemorrhage the inducible form of HSP70 specifically 
couples to inducible nitric oxide synthase and its transcription factor called Krueppel-like 
factor 6, which has been demonstrated using immunoprecipitation and immunoblotting 
analysis (Kiang, 2004). Bellmann et al. found, that HSP70 overexpressing fibrosarcoma cells 
produced two to three times more nitric oxide than control cells after treatment with 
interleukin-1β or a combination of lipopolisacharide and interferon gamma-γ. This HSP70-
mediated increase of nitric oxide production was accompanied by an enhanced transcription 
of the inducible nitric oxide synthase gene and an increased accumulation of inducible nitric 
oxide synthase mRNA and protein. This phenomenon may be specific to HSP70, because 
overexpression of other HSPs, such as HSP27 does not elevate the levels of nitric oxide. HSP70 
can modulate the cellular response to cytokines by acting on signaling elements upstream of 
p38, which acts as an enhancing factor in the activation of inducible nitric oxide synthase 
(Bellmann et al., 2000). Furthermore, induction of HSP70s protects intestinal epithelial cells 
against oxidant injury by preserving the integrity of the actin cytoskeleton and cell-cell contact 
(see detailed in part 5.4.) (Musch et al., 1999). HSP90 was reported to form a complex with 
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endothelial nitric oxide synthase to activate it, which resulted in elevated nitric oxide levels of 
cardiac cells in vitro, leading to downregulation of O2 consumption in heat-shocked cells and 
to subsequent attenuation of cellular respiration (Ilang et al., 2004). HSP90 also mediates 
cytoprotection against chemical hypoxia-induced injury via antioxidant and H2S-induced 
antiapoptotic effects (Chen et al., 2010).  
5.2 Inflammation 
Gluten-derived peptides can activate a harmful immune response in the lamina propria of 
genetically predisposed individuals (Schuppan, 2000). Antigen presentation of gluten-
derived peptides to T cells by antigen presenting cells, such as macrophages and dendritic 
cells, play a pivotal role in the pathogenesis of coeliac disease. Stimulated CD4+ T helper 
type 1 cells through release of T helper 1-type cytokines activate other immune cells, and 
therefore they have central role in controlling the immune response to gluten that causes the 
immunopathology of coeliac disease (Di Sabatino et al., 2007). HSPs (such as HSP60, 
HSP90), which can bind to peptides, are also able to induce immune response. They play 
important role in antigen presentation and activation of lymphocytes, macrophages and 
dendritic cells (Li et al., 2002). If the cell is damaged, the HSP-peptide complexes appear in 
the extracellular space and bind to certain surface molecules or receptors (such as to Toll-
like receptor 2 and Toll-like receptor 4) of antigen presenting cells, which take up these 
complexes by receptor endocytosis (Binder et al., 2004). This process leads to antigen 
presentation by major histocompatibility complex molecules to lymphocytes and finally to 
the activation of T cell pathway (,Suto & Srivastava, 1995; Dudeja et al., 2009). HSPs 
stimulate the production of inflammatory cytokines such as tumor necrosis factor alpha, 
interleukin-1, interleukin-6, interleukin-12 and C-C chemokines by monocytes, macrophages 
and dendritic cells (Tsan & Gao, 2009). These effects are mediated by the CD14/Toll-like 
receptor 2 and Toll-like receptor 4 complex leading to the activation of mitogen-activated 
protein kinase signaling pathway and nuclear factor kappa-light-chain-enhancer of 
activated B cells (Asea et al., 2000). HSP60 induces the maturation of dendritic cells and 
stimulates their activation more rapidly than lipopolisacharide and elicits a T helper type 1-
promoting phenotype (Flohé et al., 2003). Furthermore HSPs contribute to the proliferation 
and activation of natural killer cells (Multhoff, 2009), which may be involved in coeliac 
disease due to the interaction between their natural killer group 2 member D activating 
receptors and major histocompatibility complex class I polypeptide-related sequence A 
molecules expressed on epithelial cells (Gianfrani et al., 2005). The natural killer group 2 
member D/ major histocompatibility complex class I polypeptide-related sequence A 
interaction may have a pivotal role in the activation of intraepithelial immune cells and 
development of villous atrophy during coeliac disease (Hüe et al., 2004). Since Toll-like 
receptors can serve as receptors of HSPs (Tsan & Gao, 2004; Asea, 2008) and their activation 
leads to elevated expression of proinflammatory cytokines and chemokines, in this manner 
HSPs may be involved in the pathomechanism of coeliac disease (Takeda et al., 2003). Due 
to their cytokine-like effects, HSPs may serve as “danger signals” for the immune system at 
sites of tissue injury (Osterloh & Breloer, 2008). 
5.3 Apoptosis 
Apoptosis or programmed cell death is essential to the maintenance of the intestinal 
epithelial functions, because it is involved in the normal enterocyte turnover. Under 
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physiological conditions apoptotic cells of the small bowel are restricted to the tips of the 
villous and are replaced by equal number of proliferating immature crypt cells (Watson, 
1995). Increased apoptosis of enterocytes is one of the major mechanisms responsible for 
villous atrophy in coeliac disease. Apoptosis in coeliac disease may be caused directly by the 
toxic domains of gliadin peptides or it is mediated by intraepithelial and lamina propria 
lymphocytes (Di Sabatino et al., 2001). Digested wheat gliadin peptides induce apoptosis by 
the FS7-associated cell surface antigen (Fas) mediated apoptotic pathway. The ligand of Fas 
is a cell surface molecule, which belongs to the tumor necrosis factor family and binds to the 
Fas receptor and induce apoptosis of Fas-bearing cells (Ehrenschwender & Wajant, 2009). 
Fas receptor is widely expressed by many cell types, including also enterocytes. Fas was 
found on most enterocytes isolated from biopsies of patients with coeliac disease, and 
mononuclear cells of the lamina propria were shown to expressed Fas ligand (Ciccocioppo 
et al., 2001). Giovanni et al. found increased Fas and Fas ligand mRNA expression in coeliac 
disease, and this gliadin-induced apoptosis could be blocked by Fas cascade inhibiting 
agents and neutralizing antibodies (Giovannini et al., 2003). HSPs are also involved in cell 
death processes, because they may exert anti-apoptotic effects (Dudeja et al, 2009). Fas-Fas 
ligand ligation induces the binding of heat shock factor 1 to the DNA and increases the 
production of HSP72 and HSP72-induced chemokines, which than promote cell survival 
(Choi et al., 2011). HSP70 can inhibit not only the death receptor-mediated extrinsic, but also 
intrinsic apoptotic pathways, which are initiated by intracellular stress signals and regulated 
by mitochondrial proteins (Dudeja et al., 2009). During heat-induced apoptosis HSP70 
prevents the formation of pores in the mitochondrial membrane by inhibiting the 
translocation of Bax - a proapoptotic Bcl-2 family member - into the mitochondria and 
prevents cytochrome c release (Stankiewicz et al., 2005). After inhibition of HSP70, 
cytochrome c appears in the cytosol released from the mitochondria, which results in the 
stimulation of caspase-9 and caspase-3 leading to the activation of apoptotic protease 
cascade and finally to cell death (Li et al., 1997). HSP70 can modulate the calcium signaling, 
which also has a major role in the regulation of apoptosis (Rizzuto et al., 2003; Creagh et al., 
2000). Furthermore, HSP70 has been demonstrated to be a natural inhibitor of cJun N-
terminal kinase (Park et al., 2001), which through the induction of Fas ligand promotes an 
early apoptotic pathway initiated by heat shock (Volloch et al., 2000). Thereby HSP70 may 
modulate stress-activated signaling, because blocking of cJun N-terminal kinase appears to 
be involved in the protection against caspase-dependent apoptosis (Gabai et al., 2000). 
HSP70 also prevent the release of lysosomal enzymes into the cytosol by inhibiting 
lysosomal membrane permeabilization and therefore stabilizing the lysosomes (Gyrd-
Hansen et al., 2004). In contrast to other HSPs, the role of HSP60 during apoptosis is 
controversial. Recent reports suggest, that HSP60 may have an antiapoptotic effect, but early 
studies refer to its pro-apoptotic function, because it may facilitate the activation of caspase 
3 (Xanthoudakis et al., 1999). However, recently HSP60 has been described as a novel 
regulator of mitochondrial permeability transition, which contributes to a cytoprotective 
chaperone network (Ghosh et al., 2010).  
5.4 Mucosal damage 
A critical function of the intestinal mucosa is to form a barrier that separates luminal 
contents from the underlying interstitium. Integrity of the intestinal barrier is essential for 
maintaining health and preventing tissue injury. All the above mentioned processes (such as 
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oxidative stress, inflammation and enhanced epithelial cell apoptosis) lead finally to 
mucosal damage, loss of epithelial barrier function and therefore increased mucosal 
permeability (Farhadi et al., 2003). Integrity of the epithelial barrier is determined by an 
apical junctional complex that is composed of tight junction and adherens junction (Bruewer 
et al., 2006). In patients with inflammatory bowel disease the level of key tight junction 
(occludin, junctional adhesion molecule, zonula occludens 1, claudin 1) and adherens 
junction (E-cadherin, beta-catenin) proteins reduced or disappeared from the intercellular 
junctions resulting in the loss of barrier function (Ivanov et al., 2004). HSPs were reported to 
play a pivotal role in the preservation of the intestinal barrier function (Petrof et al., 2004). 
Dokladny K et al. suggested that the upregulation of occludin expression mediated by HSPs 
may be an important mechanism involved in the maintenance of intestinal epithelial tight 
junction barrier function during heat stress (Dokladny et al., 2006). Using Caco2 colonic 
epithelial cells it was shown that HSP72 can directly bind and stabilize tight junction-
associated proteins, such as zonula occludens (Musch et al., 1999). Also HSP25 takes part in 
the stabilization of cell-cell contact, and epithelial cells transfected with antisense to HSP25 
demonstrated reduced interleukin-11-mediated cytoprotection, which refer to the protective 
role of HSPs (Ropeleski et al., 2003). The connection between other HSPs and tight junction 
proteins was also demonstrated (Tsapara et al., 2006). Furthermore in the pathomechanism 
leading to villous atrophy the degradation of the extracellular matrix by matrix 
metalloproteinases may be also implicated. Matrix metalloproteinases belong to a group of 
zinc-dependent proteins, which are normally produced at very low concentrations and have 
a primary role in repairing tissue injury and remodelling (Zitka et al., 2010). In the gut of 
coeliac disease patients the expression of matrix metalloproteinase-1, matrix 
metalloproteinase-3 and a tissue inhibitor of metalloproteinases were increased, which 
suggest the importance of these proteases and protease inhibitors in the pathomechanism of 
coeliac disease (Daum et al., 1999). Furthermore, the elevated levels of tumor necrosis factor 
alpha during T cell mediated immune response in the lamina propria, which is also 
associated with mucosal injury, increased the expression of matrix metalloproteinases 
promoting mucosal degradation (Pender et al., 1997). A correlation between matrix 
metalloproteinases and HSPs was also demonstrated by Sims JD et al. Extracellular HSP90α 
was shown to activate matrix metalloproteinase-2. Cochaperones HSP70 and HSP40 
increased the association of HSP90α and matrix metalloproteinase-2 in vitro and enhanced 
the HSP90α-mediated activation of matrix metalloproteinase-2, leading to increased cell 
migration (Sims et al., 2011). HSP60 may induce tumor necrosis factor alpha and matrix 
metalloproteinase production by macrophages (Kol et al., 1998). Based on these results HSPs 
have an important regulatory role in the maintenance of epithelial barrier functions. 
6. Recent facts and research results: HSPs and coeliac disease 
Recently there are only few data in the literature about the direct connection between HSPs 
and coeliac disease. Most of our knowledge about the involvement of HSPs in the intestinal 
tract is based on the results found in other gastrointestinal disorders and gut disease 
models. Here we summarize the recent research results related to HSPs and coeliac disease 
based also on findings of our research group. Furthermore we take an outlook to other 
intestinal abnormalities with specially focus on inflammatory bowel disease because there 
are similarities between the pathomechanism of inflammatory bowel disease (mainly 
Crohn’s disease) and coeliac disease.  
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6.1 Localization of the HSPs in the gastrointestinal tract 
Studies examining the HSP expression have been shown, that however HSPs are present in 
all tissues, there are differences in their localization and amount throughout the 
gastrointestinal tract (Tanguay et al., 1993). Normally high expression of HSPs (such as 
HSP25 and HSP72) was found in gastric mucosal epithelial cells and in colon epithelial cells. 
Explanation for this phenomenon may be the fact, that these parts of the gastrointestinal 
tract are exposed to continuously high acidic pH, mechanical stress or bacterial 
fermentation, which microenvironment may promote HSP response (Kojima et al., 2003).  In 
contrast, the expression of HSPs in the small intestine is negligible under normal, stress-free 
circumstances, except the distal part of the ileum, which is exposed to high amounts of 
enteric bacteria. This luminal microflora and their metabolic products may direct the 
expression of HSPs in gut epithelial cells (Arvans et al., 2005). Under cellular stress 
conditions increased expression of HSPs were found also in other parts of the small intestine 
(Petrof et al., 2004). Generally, HSPs are predominantly localized in the epithelial cells rather 
than in the underlying lamina propria in the gastrointestinal tract suggesting that HSPs may 
have crucial role in the protection of epithelial cells preserving their function and structure 
(Kojima et al., 2003).  
6.2 HSPs in coeliac disease: recent research results 
Since mechanical, chemical or oxidative stress can impair mucosal integrity (Lewis & 
McKay, 2009) and has crucial role in the development of coeliac disease, it is important to 
understand its molecular mechanism. Because HSPs were demonstrated to have mainly 
cytoprotective function under stress circumstances (Kalmar & Greensmith, 2009), it is very 
actual to examine the potential involvement of HSPs in the pathogenesis of coeliac disease. 
Three genes of the HSP70 family are located in the major histocompatibility complex class 
III region. These genes are of particularly interest since the HSPs seem to be involved in the 
antigen processing and presentation (Pierce et al., 1991) and are thought to play a role in the 
pathogenesis in some autoimmune-like systemic disorders (Panchapakesan et al., 1992). In 
1993 Partanen et al. examined 19 families with patients suffering from celiac disease and 95 
individuals from the normal population and found that gene frequencies in the affected 
haplotypes of the heat-shock protein 70 gene cluster significantly deviated from those 
observed in the normal population. Based on their results they suggested, that 
polymorphism of human leukocyte antigen-linked HSP70 (called HSP70-2) gene may be 
involved in the pathomechanism of coeliac disease (Partanen et al., 1993). Ramos-Arroyo et 
al. studied the polymorphisms in the 5' regulatory region of the HSP70-1 gene and 
performed genomic human leukocyte antigen-DQ and -DR typing in 128 patients with 
coeliac disease and 94 healthy controls. They found that among coeliac disease patients the 
frequency of the C allele of HSP70-1 gene was significantly elevated. Furthermore, those 
individuals, who expressed the classical human leukocyte antigen alleles in coeliac disease 
and also carried the HSP70-1 CC genotype, were twelve times more likely to develop coeliac 
disease than the matched controls. The authors concluded that HSP70-1 gene might be a 
component of the high risk haplotype, playing a role as an additional predisposing gene for 
coeliac disease (Ramos-Arroyo et al., 2001). Our research group first examined the 
expression of HSP72, a member of HSP70 family in the duodenal mucosa of children with 
coeliac disease (Sziksz et al., 2010). We demonstrated increased mRNA expression and 
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protein levels of HSP72 in their duodenal mucosa localized mainly in the villous enterocytes 
and in the immune cells of the lamina propria. We suggest that HSP72 may have role in the 
defense against the gliadin-mediated cytotoxicity partly because of its antiapoptotic effects 
fostering the survival of epithelial cells. Furthermore, earlier we also demonstrated 
increased Toll-like receptor 2 and Toll-like receptor 4 expressions in the duodenal mucosa of 
patients with coeliac disease localized in the villous enterocytes and immune cells of the 
lamina propria (Szebeni et al., 2007) similarly to the tissue distribution of HSP72. Cario et al. 
showed, that activation of Toll-like receptor 2 can preserve tight junction proteins (such as 
zonula occludens 1) associated intestinal barrier integrity against stress-induced damage 
through the promotion of phosphatidylinositol 3-kinase/Akt-mediated signaling pathway 
(Cario et al., 2007). Since HSPs can serve as ligands of Toll-like receptors (Asea, 2008), our 
data suggest that HSP72-Toll-like receptor 2/Toll-like receptor 4 signaling may modify the 
immune response against gluten peptides and may alter the integrity of intestinal barrier. 
We also analyzed the HSP72 expression in coeliac disease patients maintained on gluten free 
diet and found markedly decreased levels of HSP72 in their duodenal mucosa compared to 
untreated children with coeliac disease, but its level remained higher than that in controls. 
We propose, that HSP72 as a “danger signal” for the immune cells may promote their 
protection against damage in coeliac disease. Since intact protein absorption is thought to be 
a causative factor in celiac disease, Yang et al. examined transepithelial electric resistance 
and permeability after performing heat stress in vitro using T84 human intestinal epithelial 
cells. Heat stress significantly increased protein transport across the intestinal epithelial 
monolayer and this heat stress-induced T84 monolayer barrier disruption was inhibited by 
pretreatment with HSP70 suggesting the intestinal barrier protective role of HSP70 (Yang et 
al., 2007). Examining the involvement of other HSPs in coeliac disease, Iltanen et al. 
analyzed jejunal biopsies of seventy-eight children with clinical suspicion of coeliac disease. 
They found increased expression of mitochondrial HSP65 in the epithelial cells in 80% of 
patients suffering from coeliac disease, but in only 7% of control individuals. Moreover, 
enhanced HSP65 levels were associated with higher gammadelta+ T cell densities and 
serum Immunglobulin A-class endomysial autoantibodies. They concluded that enhanced 
expression of epithelial cell stress proteins might be indicators also in some patients, which 
were excluded for the disease on biopsy (Iltanen et al., 1999). Yeboah et al. investigated the 
involvement of alphaB-crystallin, a small HSP in the pathomechanism of coeliac disease. 
Biopsy specimens of 12 celiac patients and 10 control individuals were investigated by 
immunoperoxidase screening. The intestinal epithelial cells of patients with coeliac disease 
stained more intensively for the sHSP alphaB-crystallin than that of controls. The amount 
and intracellular distribution of alphaB-crystallin in the duodenal mucosa of the patients 
with coeliac disease were closely related to the degree of villous atrophy, which may 
indicate its involvement in mucosal damage (Yeboah & White, 2001).  In summary, these 
data suggest that HSPs may be involved in the pathomechanism of coeliac disease, but 
further studies are needed to clarify their more precise role. 
6.3 HSPs in other gastrointestinal disorders 
Since stress-induced tissue damage is involved in different gastrointestinal diseases, HSPs 
were examined also in gastric ulcer (Rokutan, 2000), chronic pancreatitis (Ogata et al., 2000) 
and inflammatory bowel disease, that means Crohn’s disease and ulcerative colitis 
(Rodolico et al., 2010). Similarly to coeliac disease, inflammatory bowel disease is an 
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inflammatory disease of the intestinal tract and there are relevant overlaps in their 
pathology. In both diseases the inflammation leads to the damage of the intestinal mucosa 
resulting in enhanced permeability and impaired function of the epithelial barrier in 
genetically susceptible individuals (Festen et al., 2009). Increased HSP70 (Ludwig et al., 
1999), HSP60 and HSP10 (Rodolico et al., 2010) expression was observed in the colon 
mucosa of patients with inflammatory bowel disease. HSPs localized mainly within the 
epithelial cells and in lesser extent in the lamina propria (Rodolico et al., 2010). Protective 
functions of HSPs were demonstrated in inflammatory gastrointestinal diseases (Otaka et 
al., 2010). Using heat shock factor 1-null mice and HSP70 overexpressing transgenic mice 
HSP70 seems to have a protective role against colitis: various mechanisms may be involved 
in this process, such as the suppression of proinflammatory cytokines and cell adhesion 
molecules expression or the inhibition of programmed cell death (Tanaka & Mizushima, 
2009). A correlation between HSPs and probiotics was reported. Advantageous effect of 
probiotics was demonstrated in inflammatory bowel disease (Sartor, 2004) and one 
mechanism responsible for this can be the ability, that probiotics may induce the expression 
of HSPs (Dotan & Rachmilewitz, 2005). Tao et al. found that treatment of intestinal epithelial 
cells with the probiotic Lactobacillus GG strain induces HSP72 expression, which 
contributes to the beneficial clinical effects through preservation of cytoskeletal integrity 
(Tao et al., 2006). Using Caco-2 colonic epithelial cells Musch et al. demonstrated that HSP72 
can bind and stabilize key cytoskeleton-associated proteins, such as alpha-actinin, or tight 
junction-associated proteins, such as zonula occludens 1 (Musch et al., 1999). In summary, 
cytoprotective effects of HSPs were suggested in different gastrointestinal diseases. 
7. Future directions  
Based on these beneficial effects of HSPs they can be potential therapeutic targets in the 
future.  Using transgenic mice Mizushima et al. reported that a non-toxic HSP-inducer 
called geranylgeranylacetone, which is basically an anti-ulcer drug, achieves its anti-ulcer 
effect through induction of HSPs, which are protective against irritant-induced gastric 
lesions (Mizushima, 2010). Furthermore they reported that geranylgeranylacetone has 
protective effects against inflammatory bowel disease-related colitis and prevents lesions of 
the small intestine by the induction of HSPs. These findings predict the possibility, that 
HSPs may have therapeutic potential also in coeliac disease. Recently there are 
investigations to find HSP based therapies in other disorders, for instance the development 
of HSP-based vaccines to treat cancer with promising opportunities, because tumor derived 
HSP-peptide complexes are able to induce immunity against several malignancies as shown 
in preclinical studies (di Pietro et al., 2009). In conclusion, in the future it will be important 
to understand the precise role of HSPs in the pathomechanism of coeliac disease, because 
due to their protective effects HSPs could be regarded as potential therapeutic agents to 
treat several gastrointestinal diseases, maybe also coeliac disease.  
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